Research and development
Our ambitious programmes aim to substantially reduce global epidemic and pandemic risk. CEPI’s priority diseases include Chikungunya, COVID-19, Ebola, Lassa Fever, MERS, Mpox, Nipah, Rift Valley Fever, and novel viral threats with epidemic or pandemic potential (also known as “Disease X”).
Biosecurity
CEPI’s inaugural Biosecurity Strategy—supported by funding from Global Affairs Canada—aims to bolster global health security, underscoring its commitment to tackling emerging epidemic and pandemic threats, whether they arise naturally, accidentally or through deliberate misuse.
Call for Proposals
We invite innovators worldwide to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.
Apply now
Latest News
Blog
The pain after the bite: Tracking Chikungunya’s debilitating impact in East Africa
News
Sinergium paves the way for Latin American mRNA vaccines with new preclinical study
News
University of Oxford launches world’s first Phase II Nipah virus vaccine trial
Impact story
